Cancer Research backs ‘unique’ database

November 11, 2013
Research and Development, Sales and Marketing Cancer, Database, ICR, cansar

An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …

Novartis sheds blood diagnostics for $1.7 billion

November 11, 2013
Sales and Marketing Genoptix, Novartis, blood, grifols

Novartis has announced the sale of its blood transfusion diagnostics unit to the specialist Spanish firm Grifols for $1.67 billion.Headquartered …

Genzyme image

‘Fatal’ safety concerns throw doubt on Lemtrada

November 11, 2013
Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …

The CDF: friend and foe?

November 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low

Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …

petra_wilson

New chief executive for the International Diabetes Federation

November 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing diabetes, petra wilson

The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …

BMS image

BMS abandons hep C, diabetes and neuroscience

November 11, 2013
Sales and Marketing BMS, HIV, diabetes, hep C

Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …

Eylea image

Bayer submits Eylea in EU for DME

November 8, 2013
Sales and Marketing Bayer, DME, EMA, Eylea, FDA

Bayer HealthCare is seeking to extend the licence of its VEGF Trap-Eye, which is already marketed as Eylea in various …

brilinta image

EMA questions Brilinta data

November 8, 2013
Sales and Marketing Brilinta, EMA, astrazenca, heart, ticagrelor

The European Medicines Agency is demanding more information from AstraZeneca on its troubled heart pill Brilinta. This rounds off a …

gerald_moller

Genticel appoints vice president



November 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genticel, moeller

Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …

dna image

UK to launch DNA database

November 8, 2013
Sales and Marketing DNA, UK, crispr, genome

Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …

Alzheimer’s drug development ‘must speed up’

November 7, 2013
Research and Development, Sales and Marketing Alzheimer's, CEO, drug development

Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …

shire image

Shire to cut UK research jobs says source

November 7, 2013
Research and Development, Sales and Marketing England, Shire, UK, cuts

Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …

NHS image

PPRS: thumbs-down from pharma

November 7, 2013
Sales and Marketing ABPI, NHS, PPRS, Pfizer, VBP

A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …

Biotec Services expands with new appointments

November 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotec services

Clinical trials services firm Biotec Services International is expanding its presence in the US and the UK with three new …

£10 million boost for synthetic biology

November 6, 2013
Research and Development, Sales and Marketing Biological, Synthetic, biotech

The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …

Deepak Khanna image

PPRS to remain in UK, but drug growth curbed

November 6, 2013
Sales and Marketing ABPI, DH, Deepak Khanna, NHS, PPRS

The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …

Adheris image

inVentiv Health acquires Catalina Health

November 6, 2013
Medical Communications Adheris, catalina, inVentiv Health

Consulting and services company inVentiv Health has acquired a subsidiary of Catalina (Catalina Health) and joined it onto its own …

Roche image

ImmunoGen stops cancer trial

November 6, 2013
Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche

Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …

dan_bradbury

Profil Institute hires former Amylin chief executive

November 6, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amylin, profil institute

Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors.  “Dan Bradbury …

The Gateway to Local Adoption Series

Latest content